4Gedik S,Gur S,Atalay B,et al.Humphrey visual field analysis,visual field defects,and ophthalmic findings in patients with macro pituitary adenoma[J].Saudi Med J,2007,28:1380-1384.
5Chiu EK,Nichols JW.Sellar lesions and visual loss:key concepts in neuro-ophthalmology[J].Expert Rev Anticancer Ther,2006,6:S23-28.
6Huang WC,Lee LS.Visual field defects in patients with pituitary adenomas[J].Zhonghua Yi Xue Za Zhi (Taipei),1997,60:245-251.
7Perkins TW.CLinical decisions in glaucoma[J].Arch Ophthalmol,1994,112:1518-1519.
8Monteiro ML,Zambon BK,Cunha LP.Predictive factors for the development of visual loss in patients with pituitary macro-adenomas and for visual recovery after optic pathway decompression[J].Can J Ophthalmol,2010,45:404-408.
9Poon A,McNeill P,Harper A,et al.Patterns of visual loss associated with pituitary macroadenomas[J].Aust N Z J Ophthalmol,1995,23:107-115.
10Schmalisch K,Milian M,Schimitzek T,et al.Predictors for visual dysfunction in nonfunctioning pituitary adenomasimplications for neurosurgical management[J].Clin Endocrinol (Oxf),2012,77:728-734.
